Rare diseases
Investigational molecules
Locations
Study of Nivolumab for Patients with Liver Cancer at High Risk of Recurrence After Surgery or Ablation
GermanyStudy on the Effectiveness of Autogene Cevumeran in Patients with ctDNA Positive, Resected Stage II (High Risk) and Stage III Colorectal Cancer
GermanyLong-term Safety Study of KVD900 for Treating Angioedema Attacks in Adolescents and Adults with Hereditary Angioedema Type I or II
GermanyStudy on the Effects of Human Serum Albumin on Survival in Patients with Severe Acute-On-Chronic Liver Failure
GermanyStudy of Nivolumab and Ipilimumab for Patients with Advanced Liver Cancer (Hepatocellular Carcinoma) as First-Line Treatment
GermanyLong-term Study on Treatment Response in Chronic Hepatitis B Patients Using Bepirovirsen
GermanyStudy Comparing Sonrotoclax and Zanubrutinib with Venetoclax and Obinutuzumab for Patients with Untreated Chronic Lymphocytic Leukemia
GermanyStudy of Futibatinib with Pembrolizumab and Chemotherapy for Patients with Solid Tumors
GermanyStudy on the Effects of Bexotegrast for Patients with Idiopathic Pulmonary Fibrosis
GermanyStudy of XXB750 and Drug Combination for Patients with Heart Failure
GermanyStudy of Fianlimab and Cemiplimab for Patients with Untreated Advanced Melanoma
GermanyStudy of Datopotamab Deruxtecan and Durvalumab for Adults with Untreated Triple-Negative or Hormone Receptor-Low/HER2-Negative Breast Cancer
GermanyTell us about your condition – we search every trial in Europe and connect you with the right site.
